← Leaderboards
Michael Boyd
Adt Pharmaceuticals, Llc
$299,963
Attributed
$299,963
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$299,963 · 1
By mechanism
N43$299,963 · 1
Top collaborators
No co-investigators on record.
Most similar at Adt Pharmaceuticals, Llc
Same institution · by research overlap
- Joshua Canzoneri$413,440
- Michael R Boyd$151,000
Others in their field
Other Emerging Leaders on “Amines”
- Cornelia Marja Van Duijn · Duke University$4,516,896
- Akhgar Ghassabian · New York University School Of Medicine$4,497,447
- Dong Wang · Harvard School Of Public Health$3,757,155
- Masayuki Wasa · Boston College$3,347,573
- Christopher J Macnevin · Nirvana Sciences, Inc.$2,997,402
- Song Lin · Cornell University$2,904,520
Research focus
AminesApoptosisBaseBeta CateninBioavailableBiological AvailabilityCancer ChemopreventionCell SurvivalCyclic GmpDoseDrug KineticsDrug Or Chemical Tissue DistributionEfficacy TestingFollow-UpFormulationGeneticGenetic TranscriptionInhibitor/AntagonistIsoenzymesKnock-DownLungMalignant Neoplasm Of LungMediatingMouse Model